211 related articles for article (PubMed ID: 29349725)
1. Ki67 Proliferative Index in Carcinoid Tumors Involving Ovary.
Zhang X; Jones A; Jenkins SM; Huang Y
Endocr Pathol; 2018 Mar; 29(1):43-48. PubMed ID: 29349725
[TBL] [Abstract][Full Text] [Related]
2. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
Baker PM; Oliva E; Young RH; Talerman A; Scully RE
Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
[TBL] [Abstract][Full Text] [Related]
3. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
[TBL] [Abstract][Full Text] [Related]
4. Carcinoid tumors of the ovary.
Talerman A
J Cancer Res Clin Oncol; 1984; 107(2):125-35. PubMed ID: 6715397
[TBL] [Abstract][Full Text] [Related]
5. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity in primary ovarian carcinoid tumors.
Resl M; Reslová T; Krejcí E; Vagunda V; Nakatani Y; Miyagi E; Bedrna J; Richter P; Vorísek K
Gynecol Endocrinol; 2003 Feb; 17(1):1-6. PubMed ID: 12724012
[TBL] [Abstract][Full Text] [Related]
7. Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.
Cunningham JL; Grimelius L; Sundin A; Agarwal S; Janson ET
Acta Oncol; 2007; 46(6):747-56. PubMed ID: 17653896
[TBL] [Abstract][Full Text] [Related]
8. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
[TBL] [Abstract][Full Text] [Related]
9. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases.
Hristov AC; Young RH; Vang R; Yemelyanova AV; Seidman JD; Ronnett BM
Am J Surg Pathol; 2007 Oct; 31(10):1502-11. PubMed ID: 17895750
[TBL] [Abstract][Full Text] [Related]
10. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.
Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ
Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation.
Vora M; Lacour RA; Black DR; Turbat-Herrera EA; Gu X
Arch Gynecol Obstet; 2016 Mar; 293(3):659-65. PubMed ID: 26306985
[TBL] [Abstract][Full Text] [Related]
12. [Primary carcinoid of ovary: a clinicopathologic analysis of 17 cases].
Zhu R; Xue XW; Luo YF; Wu HW; Huo Z
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):339-343. PubMed ID: 29783799
[No Abstract] [Full Text] [Related]
13. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
Sökmensüer C; Gedikoglu G; Uzunalimoglu B
Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
[TBL] [Abstract][Full Text] [Related]
14. Metastatic carcinoid tumor to the ovary: a clinicopathologic analysis of seventeen cases.
Strosberg J; Nasir A; Cragun J; Gardner N; Kvols L
Gynecol Oncol; 2007 Jul; 106(1):65-8. PubMed ID: 17475313
[TBL] [Abstract][Full Text] [Related]
15. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.
Walts AE; Ines D; Marchevsky AM
Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865
[TBL] [Abstract][Full Text] [Related]
16. Primary Ovarian Carcinoid: Extensive Clinical Experience With an Underrecognized Uncommon Entity.
Preda VA; Chitoni M; Talbot D; Reed N; Grossman AB
Int J Gynecol Cancer; 2018 Mar; 28(3):466-471. PubMed ID: 29420361
[TBL] [Abstract][Full Text] [Related]
17. Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors.
Curran T; Tulin-Silver S; Patel K; Ward S; Schneiderman M; Harpaz N; Schwartz M; Itzkowitz S; Warner RR; Kim MK
Pancreas; 2011 Nov; 40(8):1253-7. PubMed ID: 21975435
[TBL] [Abstract][Full Text] [Related]
18. Primary ovarian carcinoid tumors.
Davis KP; Hartmann LK; Keeney GL; Shapiro H
Gynecol Oncol; 1996 May; 61(2):259-65. PubMed ID: 8626144
[TBL] [Abstract][Full Text] [Related]
19. Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung.
Garg R; Bal A; DAS A; Singh N; Singh H
Turk Patoloji Derg; 2019; 35(1):15-21. PubMed ID: 30070306
[TBL] [Abstract][Full Text] [Related]
20. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
